NeuroPace (NPCE) Gains from Investment Securities (2020 - 2026)
NeuroPace's quarterly Gains from Investment Securities came in at -$165000.0 in Q1 2026, down 8150.0% year-on-year from $2049.7 in Q1 2025, and down 1275.0% quarter-over-quarter from -$12000.0 in Q4 2025.
NeuroPace has reported Gains from Investment Securities for 7 years, with the latest figure at -$165000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities fell 8150.0% year-over-year to -$165000.0; the trailing twelve-month figure through Mar 2026 stood at -$177000.0 (down 120.14% YoY), and the FY2025 full-year result was -$14000.0, down 101.59% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at -$165000.0, down from -$12000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $10.7 million in Q3 2022, with the low at -$817000.0 in Q1 2023.
- Average Gains from Investment Securities over 5 years is $875230.8, with a median of $96000.0 recorded in 2024.
- Year-over-year, Gains from Investment Securities jumped 721.43% in 2022 and plunged 8150.0% in 2026.
- Tracing NPCE's Gains from Investment Securities over 5 years: stood at $115000.0 in 2022, then surged by 383.48% to $556000.0 in 2023, then surged by 58.45% to $881000.0 in 2024, then plunged by 101.36% to -$12000.0 in 2025, then sank by 1275.0% to -$165000.0 in 2026.
- The last three Gains from Investment Securities figures came in at -$165000.0 (Q1 2026), -$12000.0 (Q4 2025), and -$2000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -165,000.00 |
| Mar 31, 2026 | -165,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Dec 31, 2024 | 881,000.00 |
| Dec 31, 2024 | 881,000.00 |
| Sep 30, 2024 | -96,000.00 |
| Sep 30, 2024 | -96,000.00 |
| Jun 30, 2024 | 96,000.00 |
| Jun 30, 2024 | 96,000.00 |
| Dec 31, 2023 | 556,000.00 |
| Dec 31, 2023 | 556,000.00 |
| Sep 30, 2023 | 115,000.00 |
| Sep 30, 2023 | 115,000.00 |
| Jun 30, 2023 | 122,000.00 |
| Jun 30, 2023 | 122,000.00 |
| Mar 31, 2023 | -817,000.00 |
| Mar 31, 2023 | -817,000.00 |
| Dec 31, 2022 | 115,000.00 |
| Dec 31, 2022 | 115,000.00 |
| Sep 30, 2022 | 10.69 Mn |
| Sep 30, 2022 | 10.69 Mn |
| Jun 30, 2022 | -109,000.00 |
| Jun 30, 2022 | -109,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Jun 30, 2021 | 2.10 Mn |
| Jun 30, 2021 | 2.10 Mn |
| Mar 31, 2021 | 3.12 Mn |
| Mar 31, 2021 | 3.12 Mn |
| Dec 31, 2020 | -15,000.00 |
| Dec 31, 2020 | -15,000.00 |
| Jun 30, 2020 | 15,000.00 |
| Jun 30, 2020 | 15,000.00 |
| Mar 31, 2020 | -15,000.00 |
| Mar 31, 2020 | -15,000.00 |